首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism?
【24h】

Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism?

机译:突触前和突触后多巴胺能系统的联合成像是否可以提高帕金森病鉴别诊断的诊断准确性?

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: We hypothesized that combining pre- and postsynaptic quantitative information about the dopaminergic system would provide a higher diagnostic accuracy in the differential diagnosis of parkinsonism than specific striatal D(2) receptor binding alone. Therefore, the aim of the study was to introduce new semi-quantitative parameters and evaluate their ability to discriminate between Parkinson's disease (IPS) and non-idiopathic parkinsonian syndromes (non-IPS). METHODS: In 100 patients (69 IPS, 31 non-IPS), postsynaptic [(123)I]IBZM and presynaptic [(123)I]FP-CIT SPECT scans were evaluated by observer-independent techniques. The diagnostic performances of striatal dopamine transporter (DAT) and D(2) receptor binding, their respective asymmetries, and a combination of pre- and postsynaptic asymmetry were evaluated with ROC analyses. A logistic regression model was generated combining factors to calculate the probability for each patient of belonging to either diagnostic group. RESULTS: D(2) receptorbinding provided a sensitivity of 87.1% and a specificity of 72.5% with an area under the curve (AUC) of 0.866. The AUCs of other single parameters were lower than that of D(2) binding. A gain of diagnostic power (p = 0.026) was reached with a model combining pre- and postsynaptic asymmetries and D(2) binding (sensitivity 90.3%, specificity 73.9%, AUC 0.893). CONCLUSION: The combination of quantitative parameters of presynaptic DAT and postsynaptic D(2) receptor binding demonstrates superior diagnostic power in the differentiation of patients with IPS and non-IPS than the established approach based on D(2) binding alone. Striatal D(2) receptor binding and the combination of DAT and IBZM binding asymmetries are the factors contributing most in separating these diagnostic groups.
机译:目的:我们假设结合有关多巴胺能系统的突触前和突触后定量信息将比单独的特定纹状体D(2)受体结合在帕金森病的鉴别诊断中提供更高的诊断准确性。因此,该研究的目的是引入新的半定量参数并评估其区分帕金森氏病(IPS)和非特发性帕金森氏综合征(non-IPS)的能力。方法:在100例患者(69 IPS,31非IPS)中,通过独立于观察者的技术评估了突触后[(123)I] IBZM和突触前[[123] I] FP-CIT SPECT扫描。通过ROC分析评估了纹状体多巴胺转运蛋白(DAT)和D(2)受体结合,它们各自的不对称性以及突触前和突触后不对称性的组合的诊断性能。结合因素计算出逻辑回归模型,以计算每个患者属于任一诊断组的概率。结果:D(2)受体结合提供了87.1%的灵敏度和72.5%的特异性,曲线下面积(AUC)为0.866。其他单个参数的AUC低于D(2)绑定的AUC。通过将突触前和突触后不对称与D(2)结合(敏感性90.3%,特异性73.9%,AUC 0.893)相结合的模型,获得了诊断能力的提高(p = 0.026)。结论:突触前DAT和突触后D(2)受体结合的定量参数的组合表现出比仅基于D(2)结合的既定方法优越的诊断能力。纹状体D(2)受体结合以及DAT和IBZM结合不对称的组合是最有助于分离这些诊断组的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号